Elixinol Global to Present at Upcoming U.S. Investor Conferences
Elixinol Global Limited (Elixinol Globalor the Company) (ASX:EXL; OTCQX:ELLXF),a global company operating in the industrial hemp and emerging medicinal cannabis sectors, is attending the following investor conferences in October 2019.
Canaccord Genuity US Cannabis SymposiumWhen: Thursday, 3 October 2019 Where: Sheraton Centre – Toronto Presentation:1x1 and small group meetings
Alliance Global Partners Consumer Cannabis Conference When: Thursday, 3 October 2019 Where: Pierre Hotel – New York CityPresentation:1x1 and small group meetings
For more information about the conferences or to schedule a one-on-one meeting with Elixinol Global’s management, please contact your respective conference representative
Ron DufficyChief Financial Officerron.dufficy@elixinolglobal.com
About Elixinol GlobalElixinol Global Limited (ASX:EXL; OTCQX:ELLXF) is a global leader in the cannabis industry, selling hemp-derived CBD dietary supplements, hemp food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products.
Elixinol Global’s businesses include:
* Elixinol LLC (Elixinol), a manufacturer and global distributor of industrial hemp based dietary supplement and skincare products, with operations based out of Colorado, USA;
* Hemp Foods Australia Pty Ltd (Hemp Foods Australia), a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products; and
* Nunyara Pharma Pty Ltd (Nunyara), founded in 2014 to participate in the emerging Australian medicinal cannabis market. Nunyara holds a manufacturing licence and its application for cultivation to the Office of Drug Control is currently pending approval.
See more at www.elixinolglobal.com
